Trial
NCT05727878
Trial to Evaluate Safety and Efficacy of KPI-012 Ophthalmic Solution in Participants With PCED
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Combangio, Inc
Collaborators
Kala Pharmaceuticals, Inc.
Condition
Persistent Corneal Epithelial Defect
Intervention
KPI-012
Why stopped
Lack of efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-10-22